| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21977e40c08969f3e950eb43ecafe0cb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-373
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C61-06 |
| filingDate |
2005-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af600905d036cb5c031f8571decf2138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2060c20445072eb3228d90a597d136cc |
| publicationDate |
2006-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006036108-A1 |
| titleOfInvention |
Method for manufacturing prostaglandin analogue |
| abstract |
The present invention provides a new method for manufacturing a prostaglandin analogue having one or more keto groups on the 5-membered ring and/or omega chain, which comprises the step of treating a corresponding hydroxyl group containing compound with a co-oxidizer under the presence of a tetramethylpyperidine- 1 -oxyl derivative to form the desired prostaglandin analogue. The method of the invention can be carried out easily under relatively mild conditions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103764639-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103764639-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9012662-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2726472-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2726472-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015005528-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9242950-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013005817-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9212158-B2 |
| priorityDate |
2004-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |